TY - JOUR
T1 - Therapeutic Basis of Clinical Pain Modulation
AU - Kirkpatrick, Daniel R.
AU - Mcentire, Dan M.
AU - Hambsch, Zakary J.
AU - Kerfeld, Mitchell J.
AU - Smith, Tyler A.
AU - Reisbig, Mark D.
AU - Youngblood, Charles F.
AU - Agrawal, Devendra K.
N1 - Funding Information:
This work was supported by research grants R01HL116042, R01HL112597, R01HL120659 from the National Institutes of Health, USA to DK Agrawal. The content of this review is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Publisher Copyright:
© 2015 Wiley Periodicals, Inc.
PY - 2015/12/1
Y1 - 2015/12/1
N2 - Pain is a hallmark of almost all bodily ailments and can be modulated by agents, including analgesics and anesthetics that suppress pain signals in the central nervous system. Defects in the modulatory systems, including the endogenous pain-inhibitory pathways, are a major factor in the initiation and chronicity of pain. Thus, pain modulation is particularly applicable to the practice of medicine. This review summarizes the existing literature on pain modulation. Here, we critically reviewed the literature from PubMed on pain modulation published primarily within the past 5 years in high impact journals. Specifically, we have discussed important anatomical landmarks of pain modulation and outlined the endogenous networks and underlying mechanisms of clinically relevant pain modulatory methods. The Gate Control Theory is briefly presented with discussion on the capacity of pain modulation to cause both hyper- and hypoalgesia. An emphasis has been given to highlight key areas in pain research that, because of unanswered questions or therapeutic potential, merit additional scientific scrutiny. The information presented in this paper would be helpful in developing novel therapies, metrics, and interventions for improved patient management.
AB - Pain is a hallmark of almost all bodily ailments and can be modulated by agents, including analgesics and anesthetics that suppress pain signals in the central nervous system. Defects in the modulatory systems, including the endogenous pain-inhibitory pathways, are a major factor in the initiation and chronicity of pain. Thus, pain modulation is particularly applicable to the practice of medicine. This review summarizes the existing literature on pain modulation. Here, we critically reviewed the literature from PubMed on pain modulation published primarily within the past 5 years in high impact journals. Specifically, we have discussed important anatomical landmarks of pain modulation and outlined the endogenous networks and underlying mechanisms of clinically relevant pain modulatory methods. The Gate Control Theory is briefly presented with discussion on the capacity of pain modulation to cause both hyper- and hypoalgesia. An emphasis has been given to highlight key areas in pain research that, because of unanswered questions or therapeutic potential, merit additional scientific scrutiny. The information presented in this paper would be helpful in developing novel therapies, metrics, and interventions for improved patient management.
UR - http://www.scopus.com/inward/record.url?scp=84952984934&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952984934&partnerID=8YFLogxK
U2 - 10.1111/cts.12282
DO - 10.1111/cts.12282
M3 - Article
C2 - 25962969
AN - SCOPUS:84952984934
SN - 1752-8054
VL - 8
SP - 848
EP - 856
JO - Clinical and Translational Science
JF - Clinical and Translational Science
IS - 6
ER -